SAN FRANCISCO--(BUSINESS WIRE)--Levi Strauss & Co. (LS&Co.) (NYSE: LEVI) announced today that its board of directors has appointed Jeffrey J. Jones II to serve as a member of the board, effective January 21, 2026, at which time he'll serve as a member of the board's Nominating, Governance and Corporate Citizenship Committee as well as the Compensation and Human Capital Committee. Mr. Jones has served as President and CEO and Director of H&R Block, Inc. (NYSE: HRB) since 2017 and bri. ...

Montreal, Quebec--(Newsfile Corp. - December 16, 2025) - Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) ("Amex" or "the Company") is pleased to announce the closing of its acquisition (the "Transaction") of a 100% undivided interest in the 324 non-contiguous mining claims comprising 8,392.92 hectares in the Abbotsford and Hepburn Townships in the province of Ontario. The Transaction was completed pursuant to the terms and conditions of the definitive asset purchase agreement entered into betwe ...

® SAN DIEGO, Dec. 16, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology today announced an update on the INBRX-106 Phase 2/3 clinical trial in combination with Keytruda (pembrolizumab) as a first-line treatment for patients with locally advanced unresectable or metastatic head and neck squamous cell carcinoma (HNSCC) and the Phase 1/2 trial evaluating patients with checkpoint ...

  NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.Langley, British Columbia – December 16, 2025 – TheNewswire - Viva Gold Corp. (“Viva Gold” or the “Company”) (TSXV: VAU, OTCQB: VAUCF) is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced non-brokered private placement financing (the “Offering”), originally announced on December 11, 2025.The Company has upsized the Offering from up to 18,750,000 u ...

Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.NASDAQ : TLRYTilray BrandsToday's Change( 27.54 %) $ 3.01Current Price$ 13.94Key Data PointsMarket Cap$1.3BDay's Range$ 10.50 - $ 14.5552wk Range$ 3.51 - $ 23.20Volume47MAvg Vol9MGross Margin20.17 %Tilray Brands (TLRY +27.54%), global medical cannabis producer, closed Tuesday’s session at $13.94, up 27.54%. Trading volume reached 46.8 million shares, about 525% above its three-month avera ...

Group 1 - The discussion focuses on the growth of volume in the Buy Now, Pay Later (BNPL) sector, highlighting its increasing popularity among consumers in the U.S. [1] - Affirm, as a key player in the BNPL market, is noted for its ability to engage with retail investors and address their inquiries, indicating a strong interest in the company's performance and strategies [1] - The success of BNPL is attributed to the variety of payment methods available to consumers, suggesting that the flexibility and convenience offered by BNPL solutions resonate well with consumer preferences [1]

Cookie Settings We use cookies to analyze user behavior in order to constantly improve the website for you. View our Privacy Policy and Terms of Use. Necessary Analytics ...

So, should investors still expect another strong year ahead. Well, joining us now is unlimited CEO and CIO Bob Elliot. Bob, it's great to have you on.Actually, want to start right there with that BFA survey. Um, because as Mike Sani has pointed out many times before, when you see this much optimism in a survey like this, it tends to be a contrarian a contrarian indicator. Your thoughts.>> Well, I one of my favorite parts about that survey is highlighting that essentially all bears are dead in the market. Uh ...

Corweave shares down more than 20% this week alone and yet another example of AI anxiety gripping this market. The Wall Street Journal focusing on that company today. There's the tear.Coreweave staggering fall from market grace highlights AI bubble fears. So for more on where the AI trade is heading, let's welcome in Sun Cho. He is co-head of public tech investing for Goldman Sachs.Good to see you. Welcome back. >> Good to see you as Um, so I feel like this this market is is focused on debt, depreciation, a ...

Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE .I have penned many articles around the risks facing the overall market and the U.S. economy in recent months. I recently wrote about why housing is likely to face a very difficult year in 2026. OnBret Jensen has over 13 years as a marke ...